Literature DB >> 12875997

Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy.

Akiko Furuta1, Mami Noda, Satoshi O Suzuki, Yoshinobu Goto, Yoshiko Kanahori, Jeffrey D Rothstein, Toru Iwaki.   

Abstract

Glutamate excitotoxicity has been implicated in the pathophysiology of epilepsy. Systemic injection of kainic acid (KA) in the rat produces an animal model of human temporal lobe epilepsy. We examined the temporal expression of the sodium-dependent neuronal glutamate transporter, excitatory amino acid carrier 1 (EAAC1), in KA-induced rat epilepsy. As an early alteration, perinuclear deposits of EAAC1 protein were found mainly in the large pyramidal neurons at the hippocampus, neocortex, piriform cortex, and amygdala with the reduction of neuropil staining 6 hours after KA injection. Immunoelectron microscopic study revealed that the perinuclear EAAC1 immunoreactivity corresponded to the translocation to the Golgi complex. At this time point, EAAC1 mRNA was down-regulated. The intracellular aggregation of EAAC1 primarily disappeared by 24 hours. In vitro studies indicated that internalization of EAAC1 from the plasma membrane to the intracellular compartment by KA treatment was associated with the reduction of electrogenic transporter currents. Our results suggest that the transient EAAC1 internalization participates in the modulation of the transporter function preventing excessive glutamate uptake to pyramidal neurons during the early stage of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875997      PMCID: PMC1868233          DOI: 10.1016/S0002-9440(10)63705-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

Review 1.  Sorting and signaling at the Golgi complex.

Authors:  J G Donaldson; J Lippincott-Schwartz
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

2.  Localization of the high-affinity glutamate transporter EAAC1 in rat kidney.

Authors:  C Shayakul; Y Kanai; W S Lee; D Brown; J D Rothstein; M A Hediger
Journal:  Am J Physiol       Date:  1997-12

3.  Altered expression of the glutamate transporter EAAC1 in neurons and immature oligodendrocytes after transient forebrain ischemia.

Authors:  M Gottlieb; M Domercq; C Matute
Journal:  J Cereb Blood Flow Metab       Date:  2000-04       Impact factor: 6.200

4.  Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

Authors:  K Tanaka; K Watase; T Manabe; K Yamada; M Watanabe; K Takahashi; H Iwama; T Nishikawa; N Ichihara; T Kikuchi; S Okuyama; N Kawashima; S Hori; M Takimoto; K Wada
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

5.  Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

Authors:  G M Daniels; S G Amara
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Modulation of glycine-induced chloride current in acutely dissociated rat periaqueductal gray neurons by mu-opioid agonist DAGO.

Authors:  B I Min; C J Kim; J S Rhee; N Akaike
Journal:  Brain Res       Date:  1996-09-23       Impact factor: 3.252

7.  Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration.

Authors:  P Peghini; J Janzen; W Stoffel
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

8.  Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase.

Authors:  K D Sims; D J Straff; M B Robinson
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

9.  Alterations in glutamate transporter protein levels in kindling-induced epilepsy.

Authors:  H P Miller; A I Levey; J D Rothstein; A V Tzingounis; P J Conn
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

10.  Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma.

Authors:  K E Davis; D J Straff; E A Weinstein; P G Bannerman; D M Correale; J D Rothstein; M B Robinson
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

View more
  7 in total

1.  Genetic variation in neuronal glutamate transport genes and associations with posttraumatic seizure.

Authors:  Anne C Ritter; Candace M Kammerer; Maria M Brooks; Yvette P Conley; Amy K Wagner
Journal:  Epilepsia       Date:  2016-05-07       Impact factor: 5.864

2.  Unique anti-apoptotic activity of EAAC1 in injured motor neurons.

Authors:  Sumiko Kiryu-Seo; Kazushige Gamo; Taro Tachibana; Kohichi Tanaka; Hiroshi Kiyama
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

3.  Confocal Analysis of Cholinergic and Dopaminergic Inputs onto Pyramidal Cells in the Prefrontal Cortex of Rodents.

Authors:  Zi-Wei Zhang; Mark W Burke; Nicole Calakos; Jean-Martin Beaulieu; Elvire Vaucher
Journal:  Front Neuroanat       Date:  2010-06-14       Impact factor: 3.856

4.  Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1.

Authors:  Yiting Liu; Svetlana Vidensky; Alicia M Ruggiero; Susanne Maier; Harald H Sitte; Jeffrey D Rothstein
Journal:  J Biol Chem       Date:  2007-12-20       Impact factor: 5.157

Review 5.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 6.  Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System.

Authors:  Anna R Malik; Thomas E Willnow
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

Review 7.  Overview of Glutamatergic Dysregulation in Central Pathologies.

Authors:  Tanya Miladinovic; Mina G Nashed; Gurmit Singh
Journal:  Biomolecules       Date:  2015-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.